INS and type 2 diabetes mellitus: From the data generated in the present study, it would seem that fast-acting analog-based CSII could achieve good blood glucose control with fewer insulin doses over shorter periods of time compared with glargine- or detemir-based MDI which remains the most effective mode of intensive insulin therapy in poorly controlled T2DM.